Surgery Partners, Inc.
SGRY
$21.48
-$0.36-1.65%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.11B | 2.99B | 2.89B | 2.79B | 2.74B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.11B | 2.99B | 2.89B | 2.79B | 2.74B |
| Cost of Revenue | 2.37B | 2.28B | 2.20B | 2.13B | 2.10B |
| Gross Profit | 745.60M | 705.60M | 693.90M | 668.80M | 647.50M |
| SG&A Expenses | 138.70M | 123.60M | 131.20M | 122.10M | 120.90M |
| Depreciation & Amortization | 152.60M | 149.80M | 128.50M | 118.10M | 118.10M |
| Other Operating Expenses | -20.00M | -15.00M | -14.00M | -8.70M | -7.50M |
| Total Operating Expenses | 2.64B | 2.54B | 2.44B | 2.36B | 2.33B |
| Operating Income | 474.30M | 447.20M | 448.20M | 437.30M | 416.00M |
| Income Before Tax | 147.10M | 125.60M | 147.50M | 164.10M | 135.00M |
| Income Tax Expenses | 134.60M | 19.80M | 18.40M | 5.70M | -300.00K |
| Earnings from Continuing Operations | 12.50 | 105.80 | 129.10 | 158.40 | 135.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -180.60M | -166.40M | -162.90M | -157.80M | -147.20M |
| Net Income | -168.10M | -60.60M | -33.80M | 600.00K | -11.90M |
| EBIT | 474.30M | 447.20M | 448.20M | 437.30M | 416.00M |
| EBITDA | 626.90M | 597.00M | 576.70M | 555.40M | 534.10M |
| EPS Basic | -1.33 | -0.48 | -0.27 | 0.00 | -0.10 |
| Normalized Basic EPS | 0.02 | 0.00 | 0.03 | 0.02 | 0.01 |
| EPS Diluted | -1.33 | -0.48 | -0.27 | 0.00 | -0.10 |
| Normalized Diluted EPS | 0.02 | 0.00 | 0.03 | 0.03 | 0.01 |
| Average Basic Shares Outstanding | 504.49M | 504.05M | 503.63M | 503.21M | 502.45M |
| Average Diluted Shares Outstanding | 504.49M | 504.05M | 503.63M | 504.86M | 504.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |